| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $50.5M | +6.8% |
| SG&A Expense | $31.0M | +7.3% |
| Income Tax | $0 | — |
| Net Income | -$70.8M | -11.2% |
| EPS (Basic) | -$0.56 | -9.8% |
| EPS (Diluted) | -$0.56 | -9.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.6M | +42.5% |
| Current Assets | $132.8M | -24.9% |
| Total Assets | $242.7M | -20.6% |
| Current Liabilities | $7.6M | -16.3% |
| Total Liabilities | $34.0M | -15.4% |
| Stockholders' Equity | $208.7M | -21.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.1M | -14.4% |
| Capital Expenditures | $2.1M | -13.1% |
| Investing Cash Flow | $66.3M | +251.5% |
| Financing Cash Flow | $1.1M | +210.9% |
| Free Cash Flow | -$61.3M | -13.1% |